|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
+9,900.00% | +9,900.00% |
| 27/10/21 | Patient Access Solutions, Inc. Introduces CAMEO | CI |
| 24/08/21 | Cara Therapeutics Shares Rise 7% on FDA Approval of Korsuva Injection | DJ |
| Market Cap | 350K 303K 283K 259K 488K 33.29M 495K 3.32M 1.3M 16.69M 1.31M 1.28M 55.16M | P/E 2007 * |
-
| P/E 2008 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 1.39M 1.2M 1.12M 1.03M 1.93M 132M 1.96M 13.13M 5.15M 66.09M 5.2M 5.09M 218M | EV / Sales 2007 * |
-
| EV / Sales 2008 | 24.4x |
| Free-Float |
-
| Yield 2007 * |
-
| Yield 2008 | - |
| 1 week | +9,900.00% | ||
| Current month | +9,900.00% | ||
| 1 month | +9,900.00% | ||
| 3 months | +9,900.00% | ||
| 6 months | +9,900.00% | ||
| Current year | +9,900.00% |
| 1 week | 0 | 0 | |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0.01 | |
| 10 years | 0 | 0.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bruce Weitzberg
CEO | Chief Executive Officer | 66 | - |
Robert Linzalone
PRN | Corporate Officer/Principal | 66 | 01/02/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/04/26 | Other | 0 | 0% |
| 2007 | 2008 | |
|---|---|---|
| Net sales | 323K 279K 261K 239K 450K 30.71M 457K 3.06M 1.2M 15.39M 1.21M 1.19M 50.88M | 350K 303K 283K 260K 488K 33.35M 496K 3.32M 1.3M 16.71M 1.32M 1.29M 55.26M |
| Net income | -685K -593K -554K -508K -955K -65.22M -970K -6.49M -2.55M -32.69M -2.57M -2.52M -108M | -9.09M -7.86M -7.34M -6.74M -12.67M -865M -12.87M -86.15M -33.81M -434M -34.14M -33.39M -1.43B |
| Net Debt | 1.27M 1.1M 1.03M 944K 1.78M 121M 1.8M 12.07M 4.74M 60.76M 4.78M 4.68M 201M | 1.04M 896K 837K 767K 1.44M 98.57M 1.47M 9.82M 3.85M 49.4M 3.89M 3.8M 163M |
Employees
5
Sector
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/08/26 | US$0.000001 | -.--% | 10,000 |
| 31/07/26 | US$0.000001 | -.--% | 700 |
- Stock Market
- Stocks
- PASO Stock
Select your edition
All financial news and data tailored to specific country editions
















